Triple-negative breast cancer (TNBC) represents 15% of all breast cancer types, and is defined by the lack of significant estrogen receptor (ER) and progesterone receptor (PR) expression, and the absence of human epidermal receptor 2 (HER2) overexpression/amplification [1,2]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.